KDM6B and rheumatoid arthritis: JMJD3 is activated by ERK/MAPK signaling, leading to increased expression of the proliferating cell nuclear antigen (PCNA) gene through demethylase activity, ultimately resulting in an aggressive RA phenotype [49].